CAS 868540-17-4 appears in our catalog under these names: Carfilzomib, Carfilzomib, >95% (HPLC), Carfilzomib/ 99.84% (existing batch purity), Carfilzomib (PR–171), Carfilzomib, 98.00%. Offered by: Chemat Brand, Hubei YoungXin, Mikromol, TRC, TargetMol. Available pack sizes: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 250mg, 5mg.
Carfilzomib is a synthetic tetrapeptide consisting of morpholin-4-acetyl, L-2-amino-4-phenylbutanoyl, L-leucyl and L-phenylalanyl residues joined in sequence with the C-terminus connected to the amino group of (2S)-2-amino-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-1-one via an amide linkage. Used for the treatment of patients with multiple myeloma. It has a role as an antineoplastic agent and a proteasome inhibitor. It is an epoxide, a member of morpholines and a tetrapeptide.
Source: ChEBI
| Molecular formula | C40H57N5O7 |
|---|---|
| Molecular weight | 719.9 g/mol |
| IUPAC name | (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide |
| InChIKey | BLMPQMFVWMYDKT-NZTKNTHTSA-N |
| SMILES | CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4 |
Computed by PubChem (NCBI)